Latest Headlines
-
Cofactor Genomics Announces Strategic Investment By Labcorp And Ascension Ventures To Fuel Expansion Of Its OncoPrism Immunotherapy Diagnostic Across U.S. Cancer Care Networks
12/15/2025
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
-
Overture Life And CEGYR Establish First Automated Embryology Center Of Excellence To Set Global Benchmark For Reproducible IVF Outcomes Across High-Volume Fertility Networks
12/15/2025
Overture Life, the global leader in automated IVF and the first company to achieve live births from both robotic fertilization and robotic egg freezing, today announced the establishment of its first Center of Excellence for Automated Embryology in partnership with CEGYR, a flagship fertility program within the Eugin Group.
-
ALZpath And Siemens Healthineers Sign Licensing Agreement To Advance Global Access To Blood-Based Alzheimer's Disease Diagnostic Testing
12/15/2025
ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's disease and related dementias, today announced a licensing agreement with Siemens Healthineers for use of its proprietary pTau217 antibody in the development of a pTau217 assay in the expanding menu of Siemens Healthineers in vitro diagnostic (IVD) tests for Alzheimer's disease.1
-
Trinity Biotech Expands Global Rollout Of High-Capacity Column System For FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances
12/15/2025
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has secured regulatory clearances in multiple countries, enabling the expanded rollout of its next-generation high-capacity HbA1c column system for the Premier Hb9210 analyzer which is now available in more than 10 countries, including the United States.
-
BD Expands BD MAX™ System Menu With New IVDR-Certified VIASURE Assays In Partnership With Certest Biotec
12/15/2025
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX™ System.
-
UM Health-Sparrow Installs First-Of-Its-Kind Lab Automation
12/12/2025
University of Michigan Health-Sparrow activated a new, laboratory automation system that boasts drastically shorter turnaround times for lab tests. The system is among the first of its kind in the nation.
-
KVP International Acquires SafePath Laboratories And IVD Research, Expanding Its Capabilities In Diagnostics
12/12/2025
KVP International, the Better Pet Care Company™, announced the acquisition of SafePath-IVD, a leading diagnostics manufacturer and CDMO provider with FDA, ISO 13485 and USDA licenses based in Carlsbad, California.
-
Sapio Sciences Partners With The Wellcome Sanger Institute On Digital Laboratory Transformation
12/12/2025
Sapio Sciences, the science-aware AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program.
-
New Blood Test Matches Breast Cancer Patients To The Right Treatment Without A Biopsy
12/11/2025
A new type of blood test can accurately identify different types of breast cancer – meaning patients can be matched to the correct treatment without the need for a biopsy.
-
Roche Expands Automated Mass Spectrometry Menu With Antibiotics Drug Monitoring CE Mark Approval Offering Industry's Broadest In Vitro Diagnostic Menu
12/11/2025
Roche announced today that it has secured CE Mark approval for its mass spectrometry reagent pack for antibiotics drug monitoring.